SPIA
TARA icon

Steward Partners Investment Advisory’s Protara Therapeutics TARA Stock Holding History

Steward Partners Investment Advisory’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50
Closed – – 2763
2019
Q2 		$0 Buy
+50
New +$884 ﹤0.01% 2690
2018
Q4 		– Sell
-50
Closed -$4K – 1999
2018
Q3 		$4K Hold
50
– – ﹤0.01% 2225
2018
Q2 		$5K Hold
50
– – ﹤0.01% 2015
2018
Q1 		$5K Buy
+50
New +$4.55K ﹤0.01% 1807

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Steward Partners Investment Advisory's TARA Position: Q3 2019 in Review

Steward Partners Investment Advisory sold out of Protara Therapeutics (TARA) in Q3 2019, closing a stake of 50 shares.

Steward Partners Investment Advisory first reported a position in TARA in Q1 2018 and held it in 4 quarters. The position peaked at $5K in Q2 2018. 17 funds tracked by Wall St. Rank hold TARA as of Q3 2019.

  • Steward Partners Investment Advisory reported no remaining Protara Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 50 Protara Therapeutics shares in Q3 2019.
  • Steward Partners Investment Advisory first reported a position in Protara Therapeutics in Q1 2018 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Protara Therapeutics position peaked at $5K in Q2 2018.
  • 17 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2019.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2019, filed 30 Oct 2019.